Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians by Vupputuri, Madhava Rao et al.
Prevalence and functional significance of 25-hydroxyvitamin D
deficiency and vitamin D receptor gene polymorphisms in Asian
Indians1–4
Madhava Rao Vupputuri, Ravinder Goswami, Nandita Gupta, Debarti Ray, Nikhil Tandon, and Neeta Kumar
ABSTRACT
Background: Recent studies show a wide prevalence of hypovita-
minosis D in Asian Indians.
Objective: The objective was to assess the functional significance of
25-hydroxyvitamin D [25(OH)D] deficiency, vitamin D receptor
(VDR) gene, and parathyroid hormone (PTH) gene polymorphisms
in relation to bone mineral density (BMD) in urban Asian Indians.
Design: Serum total calcium, inorganic phosphorus, alkaline phos-
phatase, 25(OH)D, intact PTH, and BMD at lumbar spine, proximal
femur, and forearm were measured in 105 adult subjects. The geno-
typing related to VDR (BsmI, FokI, and TaqI) and PTH (BstBI and
DraII) gene single-nucleotide polymorphisms was carried out by
polymerase chain reaction–restriction fragment length polymor-
phism analysis.
Results: The mean serum 25(OH)D concentration in the whole
cohort was 9.8 6.0 ng/mL, which was inversely related with serum
intact PTH values (P  0.042). Ninety-nine (94.3%) of the 105
subjects had vitamin D deficiency with 25(OH)D concentrations
 20 ng/mL. The age- and body mass index (BMI)–adjusted BMD
value at the hip was higher in subjects with serum 25(OH)D values
 9.0 ng/mL than in those with values 9.0 ng/mL (0.893 0.114
compared with 0.839 0.112 g/cm2, respectively; P 0.001). The
mean forearm and spine BMD values in subjects with TT (VDR,
TaqI) or bb (PTH, BstBI) genotypes were significantly higher than
the values in subjects with Tt genotype and BB or Bb genotype,
respectively.
Conclusion: Functionally significant 25(OH)D deficiency affecting
BMD at the hip region is prevalent in urban Asian Indians. However,
variation in BMD at the spine and forearm is related to VDR and PTH
gene polymorphisms rather than to vitamin D status, at least in this
hypovitaminotic D population. Am J Clin Nutr 2006;83:
1411–9.
KEY WORDS Hypovitaminosis D, VDR, PTH, polymor-
phism, Asian Indians
INTRODUCTION
Serum 25-hydroxyvitamin D [25(OH)D] concentrations,
body mass index (BMI; in kg/m2), sex, age, and genetic factors
are the important determinants of bone mineral density (BMD;
1–4). Studies conducted as early as the 1960s by Ahuja (5) and
Gupta et al (6) reported up to 44% prevalence of osteoporosis and
early occurrence of related fractures in Asian Indians. We re-
ported wide prevalence of vitamin D deficiency and its signifi-
cance in terms of secondary hyperparathyroidism in apparently
healthy subjects residing in Delhi (7). Subnormal serum
25(OH)D concentrations could be related to poor sunshine ex-
posure and skin pigmentation. BMD is higher in Indian patients
with sporadic idiopathic hypoparathyroidism, which indicates
the beneficial effect of low concentrations of serum parathyroid
hormone (PTH) on BMD in these patients (8). Recent reports
show a wide presence of hypovitaminosis D from other parts of
northern India as well as southern India (9, 10). Only 2 studies
were done in which the relation between BMD and serum
25(OH)D was assessed in Indians (11, 12). Arya et al (11)
observed a correlation between serum 25(OH)D concentra-
tions and BMD in a cohort of 92 healthy subjects from north-
ern India. However, in healthy north Indian paramilitary
forces, no correlation between serum 25(OH)D and BMD
could be observed (12).
Among genetic factors that influence BMD, vitamin D recep-
tor gene (VDR) is the most widely studied (13, 14). Morrison et
al (15) first reported an association between BMD and VDR gene
BsmI single-nucleotide polymorphism (SNP). Subsequently, 3
other VDR gene SNPs (ApaI, TaqI, and FokI) were associated
with BMD changes in several ethnic groups (16–18). A few
studies also assessed PTH gene SNPs in relation to BMD (19,
20). No study to date has assessed the relation between BMD and
VDR and PTH gene SNPs in Asian Indians.
We assessed the relation between serum 25(OH)D concentra-
tions and BMD in a cohort of 105 apparently healthy Asian
Indian subjects after adjustment of the variation related to their
age, sex, and BMI. We also analyzed the relation between BMD
and various genotypes related to VDR gene polymorphisms and
2 PTH gene SNPs, ie, BstBI and DraII.
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SUBJECTS AND METHODS
Subjects
Study subjects included 105 healthy persons (51 men and 54
women; x SD age: 43.3 9.7 y; BMI: 24.6 3.6). The BMD
was measured in all subjects at the All India Institute of Medical
Sciences under the Indian Council of Medical Research task
force study to establish normative data of BMD in Asian Indians.
These subjects were recruited after randomization of a middle-
income population staying in a government accommodation lo-
cated at a central part of New Delhi (latitude 28.35 °N and lon-
gitude 77.12 °E; Meteorology Department, Delhi, India). Most
of the male subjects included in the current study worked indoors
as office staff, and the women were housewives. The study sub-
jects were recruited after a careful history, physical examination,
and normal baseline investigations, which included hemogram
and renal and liver function tests. Subjects taking drugs that can
affect bone mineral metabolism, such as glucocorticoids, antitu-
bercular therapy, antiepileptics, levothyroxine, and hormone re-
placement therapy, and those with diabetes mellitus were not
enrolled in the current study.
BMD was measured in all the subjects by using dual-energy
X-ray absorptiometry (QDR 4500 Acclaim Series; Hologic Inc,
Waltham, MA) at the lumbar spine (L1–L4 anteroposterior), left
proximal femur, and left forearm regions. The CV of total BMD
at various regions studied was 1%. The BMD values were also
analyzed separately for neck, trochanter, intertrochanter, and
Ward’s triangle; the femur; and ultradistal, middle, and proximal
one-third of the forearm. The BMD of the subjects was recorded
in terms of absolute mineral content (in g/cm2) at various sites.
The t and z score analyses were not used in the current study
because BMD data for a large population are yet not available for
Asian Indians. Dietary calcium intake was assessed in all the
subjects by a trained dietitian using a standard food-frequency
questionnaire and published data on the mineral composition of
Indian food (7, 21). Dietary products, including dairy products
and food fats, are not fortified with vitamin D in India, and fish
is a rare diet item.
A blood sample was drawn from the study subjects after an
overnight fast without venostasis. The serum was separated in a
refrigerated centrifuge at 2500 g for 5 min at 4 °C and stored
at 20 °C in multiple aliquots to measure concentrations of
serum total calcium, inorganic phosphorus, alkaline phospha-
tase, intact PTH (iPTH), and 25(OH)D. Serum total calcium,
inorganic phosphorus, and alkaline phosphatase were measured
in duplicate with the use of commercial kits (Roche, Mannheim,
Germany) on a semiautomated analyzer (Hitachi Photometer
4020; Boehringer, Mannheim, Germany). Intraassay and inter-
assay CVs for serum calcium, phosphorus, and alkaline phos-
phatase assays were 3.6%, 3.8%, and 3.5% and 4.8%, 5.2%, and
4.1%, respectively, in our laboratory. Serum iPTH was measured
with the use of an immunoradiometric assay (Diasorin, Stillwa-
ter, MN; normal range: 13–54 pg/mL; intraassay and interassay
CVs: 4% and 8%, respectively). Serum 25(OH)D concentrations
were estimated by using a radioimmunoassay (Diasorin; normal
range: 9–37.6 ng/mL). Subjects were classified as vitamin
D–deficient, –insufficient, and –sufficient on the basis of serum
25(OH)D concentrations of 20 ng/mL, 20 to 32 ng/mL, and
32 ng/mL, respectively, according to the recent consensus
(22–24).
In 94 of the 105 subjects, VDR and PTH gene SNPs were
analyzed by using polymerase chain reaction–restriction frag-
ment length polymorphism (PCR-RFLP) analysis. Genomic
DNA was extracted from the peripheral leukocytes in 10 mL
venous blood and collected in a Falcon tube containing 400 L
3% EDTA by the standard phenol-chloroform extraction proce-
dure (25, 26).
Written informed consent was obtained from all study sub-
jects. The Institutional Ethics Committee of the All India Insti-
tute of Medical Sciences approved the study protocol, including
BMD assessment, biochemical estimations, and VDR and PTH
gene SNP analysis in the study subjects.
Genotyping for the VDR SNPs (BsmI, FokI, and TaqI)
The VDR genotype at BsmI, TaqI, and FokI SNP sites were
assessed by using PCR-RFLP analysis as described below. We
used an ABI 9700 thermocycler (Applied Biosystems, Foster
City, CA) for PCR amplification. The polyacrylamide gel elec-
trophoresis (PAGE)–purified primers (Bio Basic Inc, East
Markham, Canada), DNA Taq polymerase, deoxynucleoside
triphosphates, and various restriction endonucleases (Fermantas
Inc, Hanover, MD) used in the study were commercially pro-
cured.
BsmI polymorphism
The forward (5-caaccaagactacaagtaccgcgtcagtg-3) and re-
verse (5-aaccagcgggaagaggtcaaggg-3) primers used to geno-
type the BsmI SNP were based on the report of Vandevyver et al
(27). The conditions for PCR amplification were as follows: 200
ng genomic DNA, 100 pmol of each primer, 200 mol each
deoxynucleoside triphosphate/L, 2.5 mmol MgCl2/L, 5 mmol
Tris-HCl/L (pH, 8.0), 10 mmol NaCl/L, 10 mol EDTA/L, 0.5
mmol dithiothreitol/L, 5% glycerol, 0.1% TritonX-100, and 1.25
U Taq DNA polymerase were constituted in a 25-L reaction.
The initial denaturation was performed at 94 °C for 3 min, fol-
lowed by 35 cycles at 94 °C for 20 s, 62 °C for 40 s, 72 °C for 1
min, and a final extension at 72 °C for 6 min. The size of the
amplicon produced after PCR was 822 base pairs (bp). After
amplification, a 5-L aliquot of PCR product was incubated at
37 °C with 4 U BsmI restriction enzyme for 12 h. The digested
products were electrophoresed on ethidium-stained 1.2% aga-
rose gel in 0.5% Tris-borate/EDTA buffer for 1 h and visualized
by using a ultraviolet transilluminator (Figure 1A).
The SNP leading to A3G substitution in intron 8 of the VDR
gene leads to the generation of a BsmI restriction site. Homozy-
gous subjects with alleles containing nucleotide A at this position
showed an intact 822-bp band and were designated as having BB
Bsm genotype (GeneBank accession no. AC004466.1). Ho-
mozygous subjects with alleles containing G at this position
showed 2 bands of 650 bp and 172 bp and were designated as bb.
Subjects with heterozygote status at this position showed all 3
bands—ie, 822, 650, and 172 bp—and were designated as Bb
(27).
FokI polymorphism
The forward (5-agctggccctggcactgactctgctct-3) and reverse
(5-atggaaacaccttgcttcttctccctc-3) primers used to genotype
FokI were based on the report of Gross et al (28) and resulted in
a 265-bp product. The constituents used for PCR were essentially
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the same as that described for the BsmI genotyping. The condi-
tions for PCR amplification were as follows: initial denaturation
at 94 °C for 10 min followed by 35 cycles at 94 °C for 30 s, 60 °C
for 30 s, 72 °C for 30 s, and a final extension at 72 °C for 10 min
(29). A 4-L amplified PCR product was digested with 4 U FokI
restriction enzyme at 55 °C for 6 h. The digested products were
resolved by using 10% PAGE.
The SNP leading to the T3C substitution at the second nu-
cleotide of exon 2 of the VDR gene resulted in the generation of
a FokI restriction site. Homozygous subjects with alleles con-
taining nucleotide T at this position showed an intact 265-bp
band and were labeled as FF. Homozygous subjects with alleles
containing nucleotide C at this position showed 2 bands of 196 bp
and 69 bp and were designated as ff. Subjects with heterozygote
status at this position showed bands of 265, 196, and 69 bp and
were designated as Ff (Figure 1B).
TaqI polymorphism
The forward (5-cagagcatggacagggagc-3) and reverse (5-
aggagaggcagcggtactg-3) primers used to genotype the TaqI
SNP were based on the report of Chang et al (30). The conditions
for PCR (25 L reaction mix) amplification were as follows:
initial denaturation at 94 °C for 5 min followed by 35 cycles at
94 °C for 30 s, 68 °C for 30 s, 72 °C for 30 s, and a final extension
at 72 °C for 5 min. The size of the amplicon produced after PCR
was 454 bp. A 20-L aliquot of PCR product was digested with
10 U TaqI restriction enzyme at 65 °C for 1 h. The digested
products were resolved by 10% PAGE for TaqI restriction anal-
ysis.
The SNP leading to the T3C substitution at nucleotide posi-
tion1171 in exon 9 of the VDR gene will lead to generation of
a TaqI restriction site. Subjects with alleles containing nucleotide
T at this position showed an intact 454 bp and were designated as
TT. Subjects with alleles containing nucleotide C at this position
showed 2 bands of 293 bp and 161 bp and were designated as tt.
Subjects with heterozygous status at this position showed all 3
bands—ie, 454, 293, and 161 bp—and were designated as Tt
(Figure 1C).
PTH gene polymorphisms (BstBI and DraII)
The primers used for studying the PTH gene BstBI and DraII
SNPs were based on the report of Sunthornthepvarakul et al (31).
The conditions for PCR amplifications and restriction analysis
were essentially the same as described in detail in our earlier
report (23). The SNP leading to the G3A substitution in intron
2 of the PTH gene results in loss of the restriction site for endo-
nuclease BstBI. Homozygous subjects with alleles containing
nucleotide G at this position showed 383- and 226-bp fragments
and were designated as BB. Homozygous subjects with alleles
containing nucleotide A at this position showed a 609-bp frag-
ment and were designated as bb. Subjects with heterozygous
status at this position showed 3 bands of 609, 383, and 226 bp and
were designated as Bb.
The SNP leading to the C3A substitution at codon 52 (CGA)
in exon 3 of the PTH gene leads to loss of restriction site for
endonuclease DraII. Homozygous subjects with alleles contain-
ing nucleotide C at this position showed 434-bp and 175-bp
fragments and were designated as DD. Homozygous subjects
with alleles containing nucleotide A at this position showed a
609-bp fragment and were designated as dd. Subjects with het-
erozygous status at this position showed 3 bands of 609, 434, and
175 bp and were designated as Dd.
Statistical analysis
The data are presented as means  SDs. Statistical analysis
was performed by using SPSS statistical software (version 10.0;
SPSS Inc, Chicago, IL). Student’s t test was used to assess the
significance of differences in mean values of age, BMI, daily
intake of dietary calcium, and concentrations of serum total cal-
cium, inorganic phosphorus, alkaline phosphatase, and iPTH in
the 2 groups of subjects with the use of a serum 25(OH)D con-
centration cutoff of 9.0 ng/mL (the lowest “normal” value of the
kit used for the estimation of 25(OH)D; group 1, 9.0 ng/mL;
group 2,9.0 ng/mL). For assessing the difference in the mean
BMD values between these 2 groups of subjects, age- and BMI-
adjusted BMD values were used. However, for analyzing the
forearm BMD, adjustment for sex was also done. The Pearson
FIGURE 1. Polymerase chain reaction–restriction fragment length poly-
morphism (PCR-RFLP) analysis of 3 VDR single-nucleotide polymorphisms
(SNPs). (A) BsmI, 1.2% agarose gel electrophoresis after digestion of 5 L
PCR products with 4 U BsmI restriction enzyme at 37 °C for 12 h. Homozy-
gous (BB) subjects showing an undigested 822-base pair (bp) product (lanes
3 and 4); heterozygous (Bb) subject showing 822-, 650-, and 172-bp frag-
ments (lane 5); homozygous (bb) subject showing 650- and 172-bp fragments
(lane 2). (B) FokI, a 10% PAGE showing RFLP obtained after digestion of 4
L PCR product with 4 U FokI restriction enzyme at 55 °C for 6 h. Homozy-
gous (FF) subjects showing an undigested 265-bp product (lanes 2 and 5);
heterozygous (Ff) subject showing 265-, 196-, and 69-bp fragments (lane 4);
homozygous (ff) subject showing 196- and 69-bp fragments (lane 3).
(C) TaqI, a 10% PAGE showing RFLP obtained after 1-h digestion of 20L
PCR product with 10 U TaqI restriction enzyme at 65 °C. Homozygous (TT)
subjects showing an undigested 454-bp product (lanes 4 and 5); heterozygous
(Tt) subjects showing 454-, 293-, and 161-bp fragments (lanes 2, 3, and 7);
homozygous (tt) subject showing 293- and 161-bp fragments (lane 6). A
100-bp DNA ladder was run in lane 1 in all the gels.
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correlation test was used to assess the relation among various
indicators and age- and BMI-adjusted BMD values. The differ-
ence in the mean value of the various biochemical and BMD
indicators in subjects with 3 different genotype groups related to
VDR and PTH gene polymorphisms was analyzed by using an
analysis of variance (ANOVA) followed by Scheffe’s test for
posthoc analysis if the ANOVA was significant. A P value 
0.05 was considered significant. Genotype distribution of the 3
VDR SNPs and 2 PTH gene SNPs in the study population was
assessed for Hardy-Weinberg equilibrium by using the chi-
square test. The linkage disequilibrium among alleles of the 3
VDR SNPs was analyzed by using the software program SHEsis
(http://202.120.7.14/analysis/myAnalysis.php; 32). Fisher’s ex-
act test was used to assess the significance of difference in the
frequency of various haplotypes related to the 3 VDR gene SNPs
in subjects with different BMD values in the SHEsis program.
RESULTS
The BMI values among the study subjects showed normal
distribution with no skewing at either end. The mean daily intake
of dietary calcium of the group was 1277 444 mg, which was
normal according to the Indian normative data published by the
Indian Council of Medical Research (33). The dietary vitamin D
content was not estimated for the study subjects because no
published data are available for vitamin D content of the dietary
items consumed in India.
The mean serum 25(OH)D concentrations observed in the
current cohort of 105 study subjects was 9.8  6.0 ng/mL; this
value did not differ significantly between men and women in the
current study (10.8 6.8 and 8.8 4.9 ng/mL, respectively; P
0.09). A significant inverse relation was observed between serum
25(OH)D and iPTH values (r  0.20, P  0.042). Of the
subjects studied, 94.3% had serum 25(OH) concentrations sug-
gestive of vitamin D deficiency (20 ng/mL) and 4.8% had
vitamin D insufficiency (20–32 ng/mL). Only 1 subject had
sufficient vitamin D nutritional status (32 ng/mL).
To study the relation between the vitamin D nutritional status
and BMD, the cohort of 105 subjects was split into 2 groups at a
serum 25(OH)D cutoff of 9.0 ng/mL (group 1: 9.0 ng/mL;
group 2: 9.0 ng/mL). The mean value of serum 25(OH)D in the
64 subjects included in group 1 (6.3  1.2 ng/mL) was signifi-
cantly (P  0.001) less than that in the 41 subjects in group 2
(15.3  6.3 ng/mL). The mean serum iPTH was significantly
higher in the group 1 than in the group 2 subjects (53.131.3 and
39.3 17.5 pg/mL, respectively; P 0.012). The 2 groups were
comparable in terms of mean age, male-to-female ratio, BMI,
daily intake of dietary calcium, and concentrations of serum total
calcium, phosphorus, and alkaline phosphatase (Table 1). The
differences in the BMD values between the 2 groups of subjects
with different serum 25(OH)D concentrations were measured
after adjustment for age and BMI. This was considered necessary
because the BMD values at hip, spine, and forearm showed
significant positive correlation with BMI (hip: r  0.38, P 
0.001; spine: r 0.19, P 0.06; forearm: r 0.20, P 0.043)
and significant inverse correlation with age (hip: r0.30, P
0.002; spine: r  0.20, P  0.047; forearm: r  0.40, P 
0.001). However, to assess the similar difference in the forearm
BMD, adjustment was also made for sex, because, in the current
group, forearm BMD was significantly less in the female than in
the male subjects (total forearm BMD: 0.563  0.055 and
0.502 0.048 g/cm2, respectively; P 0.001).
The mean BMD values of the total hip, including femoral
neck, trochanter, and intertrochanter, were significantly (P 
0.001) lower in group 1 than in group 2 (Table 1). However, no
TABLE 1
Clinical characteristics, biochemical indicators, and bone mineral density (BMD) in subjects with different serum 25-hydroxyvitamin D [25(OH)D]
concentrations1
25(OH)D 9 ng/mL
(n 64)
25(OH)D 9 ng/mL
(n 41) P2
Age (y) 42.9 9.43 44 10.2 0.54
M:F 27:37 24:17 0.44
BMI (kg/m2) 25.1 3.8 23.9 3.1 0.10
Serum calcium (mg/dL) 9.4 0.7 9.6 0.4 0.095
Serum inorganic phosphorus (mg/dL) 4.1 0.6 4.1 0.5 0.99
Serum alkaline phosphatase (IU/L) 228 68 217 64 0.41
Serum iPTH (pg/mL) 53.1 31.3 39.3 17.5 0.012
Serum 25(OH)D (ng/mL) 6.3 1.2 15.3 6.3  0.001
Daily intake of dietary calcium (mg) 1277 433 1275 465 0.99
BMD
L1–L4 AP spine (g/cm2) 0.930 0.132 0.954 0.119 0.12
Femoral neck (g/cm2) 0.727 0.109 0.779 0.105 0.002
Trochanter (g/cm2) 0.609 0.084 0.666 0.101  0.001
Intertrochanter (g/cm2) 1.006 0.141 1.072 0.142 0.003
Total hip (g/cm2) 0.839 0.112 0.893 0.114 0.001
Ward’s triangle (g/cm2) 0.583 0.141 0.592 0.296 0.59
Ultradistal forearm (g/cm2) 0.391 0.064 0.402 0.062 0.36
Mid forearm (g/cm2) 0.544 0.058 0.565 0.063 0.119
Proximal forearm (g/cm2) 0.632 0.064 0.652 0.075 0.37
Total forearm (g/cm2) 0.525 0.058 0.541 0.062 0.20
1 iPTH, intact parathyroid hormone; AP, anteroposterior.
2 P for BMDs are age- and BMI-adjusted for the spine and hip and age-, BMI-, and sex-adjusted for the forearm.
3 x  SD (all such values).
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significant difference was observed in the mean BMD at the
lumbar spine and total forearm between the 2 groups of subjects
with significantly different serum 25(OH)D concentrations (P
0.12 and 0.20, respectively). When the correlation analysis was
performed with age- and BMI-adjusted BMD values on the one
hand and various other indicators related to bone mineral ho-
meostasis on the other, a significant positive correlation was
observed between the total hip BMD value and serum 25(OH)D
(r 0.35, P 0.001). The total hip BMD also showed a signif-
icant inverse correlation with serum iPTH concentrations (r 
0.24, P  0.014). However, age- and BMI-adjusted BMD
values at the lumbar spine and total forearm showed only a trend
toward correlation with serum 25(OH)D concentrations (r 
0.19, P  0.052 and r  0.18, P  0.062, respectively) and
showed no correlation with serum iPTH values.
The genotype distribution for the VDR SNPs showed that the
study subjects were in Hardy-Weinberg equilibrium for BsmI
and FokI sites (P 0.31 and 0.69, respectively). However, at the
TaqI site, the study population was in Hardy-Weinberg disequi-
librium (P  0.001) because of the rarity of the homozygous
mutant genotype (TaqI tt4). The study subjects were in Hardy-
Weinberg equilibrium for both the PTH gene SNPs, ie, BstBI and
DraII (P 0.31 and 0.80, respectively). The linkage disequilib-
rium analysis by using the SHEsis program showed linkage of
TaqI with BsmI SNP with linkage D score of 0.607.
To assess the relation of BMD with VDR and PTH gene SNPs,
subjects with 3 genotypes related to each of the VDR and PTH
gene SNPs studied were compared (Table 2 and Table 3). The
mean BMD values of total forearm and ultradistal and proximal
one-third of forearm were significantly higher in subjects with
the TT genotype of the TaqI VDR gene polymorphism than in
subjects with the Tt/tt genotypes (Table 2). The subjects with the
TT genotype also had a higher mean lumbar spine BMD than
subjects with the Tt genotype. The subjects with the TT genotype
had 13–19% higher mean BMD values at various forearm sites
and 11% higher BMD of the total lumbar spine than subjects with
the Tt genotype. The mean BMD value of the total hip was not
significantly different among the subjects with the 3 TaqI VDR
genotypes (ANOVA, P 0.055).
The mean BMD at the forearm and lumbar spine was signif-
icantly higher in subjects with the bb genotype of the PTH gene
BstBI polymorphism than the subjects with the BB/Bb genotypes
(Table 3). No significant differences were observed in the mean
BMD at any of the studied sites among subjects with the 3
genotypes related to BsmI and FokI SNPs of the VDR gene and
the DraII SNP of the PTH gene.
To assess the role of various haplotypes constructed by using
the 3 VDR genetic loci studied [Taq1 (T/t), BsmI (B/b), and FokI
(F/f)] in determining the BMD, we divided the study cohort into
2 groups at their median BMD cutoff. The frequency of haplo-
type tbF was significantly lower among subjects with lumbar
spine BMD above the median value than the subjects with lumbar
spine BMD below the median (4.04% compared with 15.24%,
respectively, P 0.007).
DISCUSSION
The present study confirms our earlier observation of a wide
prevalence of vitamin D deficiency (94.3%) in Asian Indians
residing in Delhi (7). Recently, other investigators have also
reported a similar occurrence of vitamin D deficiency among
pregnant women from another northern Indian city, Lucknow
(latitude 26.55 °N and longitude 80.59 °E), and in postmeno-
pausal women from Tirupati in southern India (latitude 13.40 °N
and longitude 77.2 °E) (9, 10, 34). Although the subjects from
Tirupati had daily exposure of near-perpendicular tropical sun-
shine for 4–6 h, hypovitaminosis D observed in them could be
explained by their relatively dark skin complexion (10).
On the basis of the studies related to the intestinal calcium
absorption, inverse relation with serum iPTH concentration, and
protection from fracture risk, a recent consensus has suggested
that a “normal” concentration of circulating serum 25(OH)D is at
least 32 ng/mL (22–24). It is interesting that, in the current study
and using the current consensus, 94.3% of the apparently healthy
northern Indian subjects residing in Delhi were vitamin D defi-
cient. To study the relation between the vitamin D nutritional
status and BMD, we had stratified the whole cohort into 2 groups
at a serum 25(OH)D cutoff of 9.0 ng/mL [the lowest reported
normal value of the kit used for the estimation of 25(OH)D in this
study]. The significantly lower serum 25(OH)D concentrations
observed in the group 1 subjects than in the group 2 subjects in the
current study were associated with a low BMD at the hip region.
However, the effect of subnormal serum 25(OH)D concentra-
tions on BMD at the lumbar spine region was not significant. This
was further evident on correlation analysis in which serum iPTH
showed a significant inverse correlation with BMD of the hip
region but not with BMD of the spine and forearm regions. Thus,
it seems that 25(OH)D deficiency coupled with consequently
elevated serum PTH is most detrimental for the BMD at the hip
region in urban Asian Indian subjects. The pattern of a significant
relation between serum 25(OH)D concentrations and hip BMD
but not with lumbar spine or forearm BMD observed in the
current study is in accordance with the observation of Arya et al
(11) in Indians. Although several investigators reported signifi-
cantly lower hip BMDs in both premenopausal and postmeno-
pausal white subjects with low serum 25(OH)D concentrations
(1, 2, 35–37), changes observed for the lumbar spine and forearm
BMDs have been variable (35–40). Besides, vitamin D supple-
mentation was shown to have beneficial effect predominantly on
the BMD at the hip rather than at the forearm (41, 42).
Differential effects of vitamin D deficiency on BMD at various
sites possibly involve factors other than hypovitaminosis D.
In this context, genetic variation related to VDR polymor-
phism was extensively studied in various populations (13, 14).
Among the 3 VDR SNPs studied by us, subjects with TaqI-TT
genotype had a significantly higher BMD at the forearm than
did subjects with Tt and tt genotypes. In 1995, Spector et al
(43) first reported an association of the TT genotype of TaqI
polymorphism with significantly higher BMD. Recently,
Nguyen et al (44) reported a lower risk of femoral fracture in
postmenopausal women with the TT genotype. Liu et al (13)
reviewed studies of VDR gene SNPs and variation in the
BMD. Of the 4 VDR SNPs, variation in the genotype related
to TaqI (TT homozygotes) and BsmI (bb homozygotes) poly-
morphisms were reported to be associated with higher BMD
(13). A significant linkage with 97% concordance between
TaqI and BsmI SNPs was shown in the white subjects (15).
Because of the linkage between TaqI and BsmI, it is difficult
to segregate the individual effect of genotype related to these
2 sites on the BMD. In the current study, the lower D score
observed between TaqI and BsmI SNPs (0.607) could possibly
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be due to the fact that the study population was not in Hardy-
Weinberg equilibrium at the TaqI site as a result of the relative
rarity of the tt genotype. The higher mean spine and forearm
BMDs in subjects with the TT genotype related to the TaqI
SNP but not among subjects with the bb genotype (BsmI) or
with the FokI SNP indicated the predominant influence of the
TaqI SNP in determining the variation of BMD in Asian
Indian subjects. The importance of the t allele in TaqI SNP in
determining BMD in Asian Indian subjects was further con-
firmed on haplotype analysis. The frequency of the tbf hap-
lotype was significantly higher in subjects with a spine BMD
value below the median than in subjects with a BMD value
above the median (15.24% and 4.04%, respectively). Studies
assessing the variation in the BMD with PTH gene SNPs are
limited (19, 20). In the current study, subjects with the
BstBI-BB genotype showed a lower mean BMD at the forearm
and spine than did subjects with the bb genotype. This finding
of the current study is different from that reported in Chinese
and Japanese populations (19, 20).
The effect of VDR polymorphisms on BMD was variable in
several studies (13, 45–47). Such variability was postulated to be
due to the masking of the VDR gene–related effect under differ-
ent environmental conditions, including dietary calcium intake
(13, 46). Kiel et al (46) observed the effect of BsmI VDR SNP
only in subjects with dietary calcium intakes 800 mg/d. Sim-
ilarly, Rubin et al (45) could relate TaqI SNP to BMD only when
the daily intake of dietary calcium was684 mg. However, the
results of the recent studies have shown an association of VDR
TaqI polymorphism with BMD even under calcium-deprived
states in subjects with the tt genotype (47). In the current study,
a significantly lower BMD at the forearm and lumbar spine was
observed in subjects with the Tt genotype (TaqI SNP) even in the
presence of vitamin D deficiency.
The mechanism related to differences in the VDR expression
or stability in relation to VDR polymorphism was a subject of
study to date (48–50). Crofts et al (48) in 1996 showed a higher
VDR mRNA expression in the peripheral leukocytes of subjects
with a T allele than in those of subjects with a t allele of VDR TaqI
SNP. Subsequently, Verbeek et al (50) in 1997 showed 30%
lower reverse transcriptase–PCR product was derived from the t
allele mRNA obtained from the peripheral leukocytes than from
that derived from the T allele. However, Yamagata et al (49)
could not associate VDR mRNA expression with BMD. The role
of other genes in linkage with various VDR SNPs cannot be
excluded as the cause of the variation in the BMD associated with
VDR polymorphisms.
To conclude, vitamin D deficiency is present in most of the
Asian Indians living in Delhi. Such vitamin D deficiency when
coupled with higher serum PTH concentrations has functional
relevance, as indicated by the significantly low BMD, especially
at the hip region. Moreover, the genetic factors also influence the
BMD in the subjects, as reflected by a significantly lower fore-
arm BMD in subjects with the Tt/tt genotype related to the TaqI
SNP of the VDR gene and the BB/Bb genotype of the BstBI SNP
of the PTH gene.
This work received the AR Seth Award for the Best Research work of the
year at the 35th annual meeting of the Endocrine Society of India, New Delhi,
India, November 2005.
MRV performed the vitamin D receptor gene PCR-RFLP study, analyzed
the data, and wrote the manuscript. RG designed the work; standardized
the PCR-RFLP assay for the vitamin D receptor and parathyroid hormone
TABLE 3
Clinical characteristics, biochemical indicators, and bone mineral density (BMD) in subjects with different PTH genotype groups1
BstBI DraII
BB
(n 54)
Bb
(n 30)
bb
(n 9)
DD
(n 51)
Dd
(n 34)
dd
(n 8)
Age (y) 45.8 10.32 44.0 10.4 39.9 10.5 45.6 11.3 44.6 9.4 38.5 6.0
M:F 22:32 18:12 6:3 29:22 14:20 3:5
BMI (kg/m2) 24.6 3.9 25.3 4.0 24.3 2.7 24.6 3.2 25.1 4.7 24.7 4.1
Serum total calcium (mg/dL) 9.4 0.7 9.7 0.5 9.8 0.2 9.6 0.6 9.6 0.6 9.3 0.5
Serum inorganic phosphorus (mg/dL) 4.1 0.6 4.0 0.6 3.9 0.2 4.0 0.6 4.1 0.4 4.0 0.5
Serum alkaline phosphatase (IU/L) 223 71 233 48 222 68 237 64 216 62 203 55
Serum iPTH (pg/mL) 49.0 34.8 42.5 25.0 56.5 24.8 44.5 25.8 54.0 38.9 39.6 22.5
Serum 25(OH)D (ng/mL) 9.2 5.2 10.1 5.9 14.6 11.4 10.2 7.0 9.8 5.4 9.9 5.5
BMD (g/cm2)
L1–L4 AP spine (g/cm2)3 0.932 0.125a 0.880 0.115a 1.066 0.138b 0.931 0.142 0.927 0.124 0.914 0.117
Femoral neck (g/cm2) 0.755 0.119 0.714 0.115 0.781 0.084 0.742 0.104 0.745 0.136 0.752 0.113
Trochanter (g/cm2) 0.626 0.099 0.615 0.106 0.666 0.076 0.635 0.095 0.616 0.113 0.611 0.053
Intertrochanter (g/cm2) 1.041 0.157 0.990 0.148 1.057 0.088 1.027 0.135 1.022 0.178 1.029 0.124
Total hip (g/cm2) 0.858 0.124 0.819 0.120 0.901 0.084 0.857 0.110 0.840 0.145 0.848 0.086
Ward’s triangle (g/cm2) 0.613 0.143 0.493 0.314 0.610 0.096 0.549 0.258 0.600 0.162 0.616 0.099
Ultradistal forearm (g/cm2) 0.387 0.067 0.390 0.051 0.437 0.056 0.397 0.066 0.381 0.056 0.409 0.063
Mid forearm (g/cm2) 0.545 0.069 0.552 0.051 0.597 0.054 0.553 0.068 0.545 0.057 0.578 0.060
Proximal forearm (g/cm2) 0.637 0.080 0.643 0.055 0.694 0.074 0.648 0.082 0.633 0.058 0.663 0.064
Total forearm (g/cm2)3 0.519 0.067a 0.526 0.047a 0.583 0.057b 0.532 0.069 0.517 0.052 0.542 0.060
1 iPTH, intact parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D; AP, anteroposterior.
2 x  SD (all such values).
3 Within a genotype group, means with different superscript letters are significantly different, P 0.05 (ANOVA with Scheffe’s test).
25(OH)D DEFICIENCY AND VDR GENE POLYMORPHISMS 1417
 by on O
ctober 25, 2010 
w
w
w
.ajcn.org
D
ow
nloaded from
 
genes; conducted the biochemical analysis, including serum total cal-
cium, phosphorus, and alkaline phosphatase; and supervised the study,
including analysis of the data and writing and editing of the manuscript.
NG performed the 25(OH)D and serum PTH assays. DR helped in the
vitamin D receptor polymorphism analysis. NT helped organize the bone
mineral data estimation. NK helped recruit volunteers for the study. None
of the authors had a personal or financial conflict of interest.
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